Italy
React4Life is an Italian biotech company founded in 2016 with the slogan "Mirroring Human Complexity." The company leverages its revolutionary MIVO® technology, developed over two decades of academic research, to create organ-on-chip systems that accurately replicate human biology in the lab. By overcoming the limitations of traditional in vitro assays and animal models, the MIVO® platform enhances the reliability and predictivity of various applications in drug testing, personalized medicine, immuno-oncology, dermocosmetics, and nutraceuticals.
React4Life has garnered international recognition, serving hundreds of clients globally and earning a reputation for customized, cutting-edge solutions. The company's most recent investment was a Debt Financing round on 01 March 2022.
With its focus on Biotechnology, Health Care, and Life Sciences, React4Life is at the forefront of transforming the preclinical research landscape. To learn more, visit www.react4life.com.
